Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
4,075.00
+35.00 (0.87%)
At close: Jan 23, 2026
Korea Arlico Pharm Market Cap
Korea Arlico Pharm has a market cap or net worth of 62.46 billion as of January 23, 2026. Its market cap has increased by 14.79% in one year.
Market Cap
62.46B
Enterprise Value
95.00B
Revenue
205.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,075.00
Market Cap Chart
Since February 12, 2018, Korea Arlico Pharm's market cap has decreased from 207.83B to 62.46B, a decrease of -69.95%. That is a compound annual growth rate of -14.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 62.46B | -4.68% |
| Dec 30, 2025 | 65.52B | 23.73% |
| Dec 30, 2024 | 52.95B | -39.39% |
| Dec 28, 2023 | 87.36B | -12.98% |
| Dec 29, 2022 | 100.39B | -14.71% |
| Dec 30, 2021 | 117.71B | -17.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris AI Pharma | 90.86B |
| Sinsin Pharmaceutical | 87.38B |
| GL Pharm Tech | 81.04B |
| Optipharm.CO.,LTD | 73.35B |
| Sinil Pharmaceutical | 66.89B |
| Cosmax Nbt | 64.13B |
| Jin Yang Pharmaceutical | 63.71B |
| RP Bio | 55.81B |